Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2

Shumei Song1, Baoxiang Guan, Taoyan Men

  • 1Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Insights

Retinoic acid receptor-beta2 (RAR-beta2) suppresses esophageal tumor growth by downregulating cyclooxygenase-2 (COX-2). This mechanism was observed in some cell lines and oral leukoplakia tissues, suggesting RAR-beta2

Area of Science:

  • Molecular Oncology
  • Cancer Biology

Background:

  • Retinoic acid receptor-beta2 (RAR-beta2) is investigated as a potential tumor suppressor in various cancers.
  • Understanding the molecular mechanisms of RAR-beta2's function is crucial for cancer therapy development.

Purpose of the Study:

  • To investigate the role of RAR-beta2 in esophageal cancer.
  • To elucidate the molecular mechanisms underlying RAR-beta2's antitumor activity, particularly its relationship with cyclooxygenase-2 (COX-2).

Main Methods:

  • Transfection of RAR-beta2 cDNA into esophageal cancer cell lines (TE-1, TE-8).
  • Assessment of tumor cell growth in vitro and tumor formation in nude mice.
  • Analysis of RAR-beta2 and COX-2 mRNA expression in cell lines and patient tissue specimens.
  • Inhibition of COX-2 expression using antisense vectors.

Main Results:

  • RAR-beta2 suppressed tumor growth and formation in TE-8 cells but not TE-1 cells.
  • RAR-beta2's antitumor activity correlated with the suppression of cyclooxygenase-2 (COX-2) expression.
  • Antisense RAR-beta2 induced COX-2 expression, and blocking COX-2 diminished RAR-beta2's effect.
  • RAR-beta2 expression was associated with low COX-2 levels in esophageal cancer tissues.
  • RAR-beta2 induction in oral leukoplakia correlated with reduced COX-2 and clinical improvement.

Conclusions:

  • RAR-beta2 exerts antitumor effects in some esophageal cancer cells, partly mediated by suppressing COX-2.
  • The interplay between RAR-beta2 and COX-2 is a significant factor in esophageal tumorigenesis.
  • Further research is warranted to explore targeting COX-2 to modulate RAR-beta2 activity in various cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...